Authors:
Takakura, S
Minoura, H
Shimoshige, Y
Minoura, K
Kawamura, I
Fujiwara, T
Saitoh, T
Shimojo, F
Seki, J
Goto, T
Citation: S. Takakura et al., Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy, DRUG DEV R, 54(1), 2001, pp. 27-34
Authors:
Takeshita, S
Kawamura, I
Yasuno, T
Kimura, C
Yamamoto, T
Seki, J
Tamura, A
Sakurai, H
Goto, T
Citation: S. Takeshita et al., Amelioration of insulin resistance in diabetic ob/ob mice by a new type oforally active insulin-mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode, J INORG BIO, 85(2-3), 2001, pp. 179-186
Authors:
Yamamoto, T
Takakura, S
Kawamura, I
Seki, J
Goto, T
Citation: T. Yamamoto et al., The effects of zenarestat, an aldose reductase inhibitor, on minimal F-wave latency and nerve blood flow in streptozotocin-induced diabetic rats, LIFE SCI, 68(12), 2001, pp. 1439-1448
Authors:
Ohara, F
Yamamoto, N
Maeda, K
Ozaki, T
Seki, J
Goto, T
Citation: F. Ohara et al., Protective effect of FR183998, a Na+/H+ exchange inhibitor, against postischernic injury after normothermic and prolonged hypothermic ischemia in isolated perfused rat hearts, JPN J PHARM, 87(2), 2001, pp. 110-116
Authors:
Sawada, M
Matsuo, M
Hagihara, H
Tenda, N
Nagayoshi, A
Okumura, H
Washizuka, K
Seki, J
Goto, T
Citation: M. Sawada et al., Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells, EUR J PHARM, 431(1), 2001, pp. 11-16
Authors:
Kawamura, I
Takeshita, S
Fushimi, M
Mabuchi, M
Seki, J
Goto, T
Citation: I. Kawamura et al., Induction of choleresis by immunosuppressant FK506 through stimulation of insulin-like growth factor-I production in the liver of rats, EUR J PHARM, 419(1), 2001, pp. 99-105
Citation: N. Hosogai et al., Reciprocal regulation of cyclic GMP content by cyclic GMP-phosphodiesterase and guanylate cyclase in SHR with CsA-induced nephrotoxicity, BR J PHARM, 134(5), 2001, pp. 995-1002
Authors:
Sasaki, Y
Noguchi, T
Seki, J
Giddings, JC
Yamamoto, J
Citation: Y. Sasaki et al., Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats, THROMB HAEM, 83(5), 2000, pp. 722-727
Authors:
Inoue, T
Kawamura, I
Matsuo, I
Aketa, M
Mabuchi, M
Seki, J
Goto, T
Citation: T. Inoue et al., Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats, TRANSPLANT, 70(5), 2000, pp. 774-779
Authors:
Shimoshige, Y
Ikuma, K
Yamamoto, T
Takakura, S
Kawamura, I
Seki, J
Mutoh, S
Goto, T
Citation: Y. Shimoshige et al., The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats, METABOLISM, 49(11), 2000, pp. 1395-1399
Authors:
Yamakuni, H
Sawai, H
Maeda, Y
Imazumi, K
Sakuma, H
Matsuo, M
Mutoh, S
Seki, J
Citation: H. Yamakuni et al., Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs, J PHARM EXP, 292(3), 2000, pp. 1002-1007
Authors:
Taka, T
Konishi, Y
Slon-Usakiewicz, J
Medvedkin, V
Tsuda, Y
Okada, Y
Seki, J
Yamamoto, J
Citation: T. Taka et al., Inhibitory effect of various thrombin inhibitors on shear-induced plateletfunction and dynamic coagulation, EUR J PHARM, 406(2), 2000, pp. 181-189
Authors:
Ikarugi, H
Taka, T
Nakajima, S
Noguchi, T
Watanabe, S
Sasaki, Y
Haga, S
Ueda, T
Seki, J
Yamamoto, J
Citation: H. Ikarugi et al., Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans, J APP PHYSL, 86(1), 1999, pp. 133-138
Authors:
Marusawa, H
Setoi, H
Kuroda, A
Sawada, A
Seki, J
Motoyama, Y
Tanaka, H
Citation: H. Marusawa et al., Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A(2) receptor antagonists, BIO MED CH, 7(11), 1999, pp. 2635-2645
Authors:
Yamamoto, J
Taka, T
Nakajima, S
Ueda, M
Sugimoto, E
Sasaki, Y
Muraki, T
Seki, J
Watanabe, S
Citation: J. Yamamoto et al., A shear-induced in vitro platelet function test can assess clinically relevant anti-thrombotic effects, PLATELETS, 10(2-3), 1999, pp. 178-184
Authors:
Noguchi, T
Sasaki, Y
Seki, J
Giddings, JC
Yamamoto, J
Citation: T. Noguchi et al., Effects of voluntary exercise and L-arginine on thrombogenesis and microcirculation in stroke-prone spontaneously hypertensive rats, CLIN EXP PH, 26(4), 1999, pp. 330-335
Citation: T. Taka et al., Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress, HAEMOSTASIS, 29(4), 1999, pp. 189-196
Authors:
Ohara, F
Sugimoto, T
Yamamoto, N
Ohkubo, K
Maeda, K
Ozaki, T
Seki, J
Goto, T
Citation: F. Ohara et al., Preischemic and postischemic treatment with a new Na+/H+-exchange inhibitor, FR183998, shows cardioprotective effects in rats with cardiac ischemia and reperfusion, J CARDIO PH, 34(6), 1999, pp. 848-856
Authors:
Otsubo, T
Maesaki, S
Hossain, MA
Yamamoto, Y
Tomono, K
Tashiro, T
Seki, J
Tomii, Y
Sonoke, S
Kohno, S
Citation: T. Otsubo et al., In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus, ANTIM AG CH, 43(3), 1999, pp. 471-475
Authors:
Ohara, F
Sugimoto, T
Yamamoto, N
Ohkubo, K
Ozaki, T
Maeda, K
Seki, J
Goto, T
Citation: F. Ohara et al., Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: In comparison with other cardioprotective compounds, JPN J PHARM, 80(4), 1999, pp. 295-302
Authors:
Kato, Y
Kita, Y
Nishio, M
Hirasawa, Y
Ito, K
Yamanaka, T
Motoyama, Y
Seki, J
Citation: Y. Kato et al., In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist, EUR J PHARM, 384(2-3), 1999, pp. 197-202